Skip to main content

Table 2 Physicians’ barriers to screen patients with rheumatoid arthritis for hyperlipidemia with their respective priority votes

From: Views of primary care physicians and rheumatologists regarding screening and treatment of hyperlipidemia among patients with rheumatoid arthritis

LevelSub-levelRheumatologist Votes (%)aPCP Votes (%)a
Physician LevelTotal Votes, %82.742.5
Lack of time34.01.7
Conflict regarding ownership of hyperlipidemia screening25.910.8
Lack of training and knowledge of hyperlipidemia guidelines17.919.2
Focus only on RA4.9
Physician prioritization of RA symptomology over preventive measures10.0
Lack of physician knowledge about RA0.8
Patient LevelTotal Votes, %7.444.2
Complexity of RA and its treatment2.59.2
Patient prioritization of RA symptomology over preventive measures2.59.2
Patient expectations1.8
Patient already on multiple medications0.60.0
Side effects of RA medications and RA drug interactions0.0
Comorbidities0.0
Patient’s barriers with transportation0.0
Multiple blood draws0.08.3
Side effects of statins and drug interactions with statins0.05.0
Poor patient compliance with medical care0.09.2
Patients’ lack of awareness of CVD risk3.3
System LevelTotal Votes, %9.913.3
Lack of care coordination6.811.7
Financial barriers (limited insurance coverage, cost of repeating labs)3.10.0
Lack of financial incentive for screening1.7
  1. RA Rheumatoid arthritis, CVD Cardiovascular disease. 0% = that sub-level emerged during the brainstorming session but did not receive votes. “--” = the sub-level did not emerge in the respective group
  2. aTotal votes are calculated based on the number of participating physicians. Each physician had a total of 6 votes (3 for the most important, 2 votes for the second most important, and 1 for the third most important statement). Hence, 27 rheumatologist participated × 6 votes each = 162 votes; 20 PCPs participated × 6 votes = 120 votes